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Abstract
Metabolomic based approaches have gained much attention in recent years due to their promising potential
to deliver objective tools for assessment of food intake. In particular, multiple biomarkers have emerged for
single foods. However, there is a lack of statistical tools available for combining multiple biomarkers to infer
food intake. Furthermore, there is a paucity of approaches for estimating the uncertainty around biomarker
based prediction of intake.
Here, to facilitate inference on the relationship between multiple metabolomic biomarkers and food
intake in an intervention study conducted under the A-DIET research programme, a latent variable model,
multiMarker, is proposed. The proposed model draws on factor analytic and mixture of experts models,
describing intake as a continuous latent variable whose value gives raise to the observed biomarker values.
We employ a mixture of Gaussian distributions to flexibly model the latent variable. A Bayesian hierarchical
modelling framework provides flexibility to adapt to different biomarker distributions and facilitates prediction
of the latent intake along with its associated uncertainty.
Simulation studies are conducted to assess the performance of the proposed multiMarker framework, prior
to its application to the motivating application of quantifying apple intake.
Keywords: Latent variable models, factor analysis, mixture of experts, metabolomics, ordinal regression
1 Introduction
Dietary biomarkers have emerged in recent years as objective measures of food intake (Baldrick et al. (2011)). A
dietary biomarker is a small molecule called a metabolite that can provide information on the level of intake of a
food (Gao et al. (2017), Dragsted et al. (2018)). In recent years, many biomarkers have emerged for a range of
foods. The importance of such biomarkers stems from the fact that classical dietary assessment approaches rely
on self-reported data which can be subjective and biased, and such issues are well documented in the literature
(e.g. Bingham (2002), Kipnis et al. (2002), Subar et al. (2003), Lloyd et al. (2019), Siddique et al. (2019)). As
a consequence, dietary biomarkers have emerged as a potential objective tool to aid food intake assessment.
As the biomarker field progressed and the analytical tools improved, the number of biomarkers identified as
potential biomarkers of intake has increased. Indeed, there are now multiple biomarkers for individual foods.
However, there is a paucity of statistical tools for modelling the relationship between multiple biomarkers
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and food intake. The work to date has employed biomarkers as panels to classify intake into categories, e.g.
consumers and non-consumers. For example, Garcia-Aloy et al. (2017) propose a panel of biomarkers for cocoa
intake, which is employed to estimate cocoa consumption or non-consumption through a forward stepwise
logistic regression model. Rothwell et al. (2014) propose a partial least squares discriminant analysis (PLS-DA)
approach to distinguish between low and high consumption of coffee in a sample of individuals, using a panel of
three coffee-specific biomarkers. Recent work by Vázquez-Manjarrez et al. (2019) on discovery and validation
of banana intake biomarkers also employs a PLS-DA approach to detect low, medium and high consumption
of banana. The proposed panel of biomarkers proved to be effective in distinguishing between low and high
consumers, while medium consumers were difficult to separate from the two extremal groups. Gürdeniz et al.
(2016) present a PLS-DA approach to detect beer intake (consumers versus non-consumers) using a panel of
aggregated biomarkers. While the aforementioned approaches avail of a panel of biomarkers, they provide a
categorical quantification of intake, not an estimation of the quantity of intake, nor its associated uncertainty.
The A-DIET research programme (www.ucdnutrimarkers.com/a-diet) aims to identify new metabolomic
biomarkers of dietary intake, and here provides the motivating context. Data from a panel of four novel
metabolomic biomarkers were collected from an intervention study, where a group of participants consumed
three different food quantities (of apple), over a three week period. The statistical challenge is to infer the
relationship between the biomarkers and food intake, and to predict intake from the panel of biomarkers alone.
Here, to infer the relationship between multiple biomarkers and food intake we have developed the “multi-
Marker” model. MultiMarker relies on a factor analytic latent variable construct (Knott & Bartholomew 1999) to
capture the relationship between the panel of observed biomarkers and the unobserved intake. The distribution
of the latent factor (i.e. the unobserved food intake) is expressed through a flexible mixture model. Moreover,
to improve prediction, multiMarker avails of a mixture of experts framework (Jacobs et al. (1991), Gormley &
Frühwirth-Schnatter (2019)), such that the biomarker data first informs the predicted level of intake (relative to
the most likely food quantity), with the more refined predicted intake then resulting from the factor analytic
aspect of multiMarker. The model is developed in a Bayesian framework, naturally allowing for uncertainty
quantification and therefore providing more informed quantification of intake.
Traditional factor analysis models assume that the correlation structure between a collection of observed
variables can be represented in terms of a linear combination of a lower number of latent variables, the factors
(Knott & Bartholomew 1999). The latent variable(s) are often assumed to follow a Gaussian distribution, and
many extensions have been proposed. Allowing an infinite number of factors to facilitate greater modelling
flexibility has been proposed by Bhattacharya & Dunson (2011), and Murphy et al. (2020) extend the framework
to an infinite mixture of infinite factor analysers. When in the presence of an heterogeneous population, Montanari
& Viroli (2010) proposed an heteroscedastic factor mixture analysis model, where factors are distributed according
to a mixture of multivariate Gaussian distributions. Relaxations of the Gaussianity assumption for the factors
have been considered by many authors, see for example McLachlan et al. (2007), Murray et al. (2014) and Lin
et al. (2016). An extension of the factor mixture analysis approach to multivariate binary response data has
been considered by Cagnone & Viroli (2012). Galimberti et al. (2009) propose an approach to dimensionality
reduction in factor mixture analysis models, where factor loadings are shrunk through a penalized likelihood
approach. Robustification of factor analysis models was addressed by Pison et al. (2003), who introduced a
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method to address outliers. A further issue with factor analytic models is non-identifiability, see for example
Lopes & West (2004), Ročková & George (2016) and Frühwirth-Schnatter & Lopes (2018).
While much factor analytic research has focused on two common issues, the number of factors to employ
and the distribution to adopt, attempting to model the scale of the latent factors has received little attention.
Typically the latent factors are perceived as instrumental tools to achieve a lower-dimensional representation of
the data at hand. On the contrary, motivated by the application, our approach is focused on a single latent
variable that is a proxy for the latent intake. Information on the scale of this latent variable is available and
necessary in order to provide practically useful quantification of intake. While the availability of such information
also ensures the multiMarker model is identifiable, unlike general factor analytic models, it adds complexity to
inferring the latent variable which is no longer a simple instrument. Modelling the latent factor via a mixture
model allows for a flexible framework, but introduces the issue of properly modelling mixture weights. Indeed,
mixture components have the role of locating different regions in the intake range for the latent variable, where
the order of such regions is relevant and should not be ignored. To this end, we embed the model for the
latent variable in a mixture of experts framework, where the weights are modelled as functions of the observed
biomarkers. Further, when modelling the weights we directly account for the ordinal nature of the food quantity
data via an ordinal regression model (Agresti 1999), employing the robust Cauchit link function (Morgan &
Smith (1992)). Prediction of the latent intake and its associated uncertainty is available through the latent
variable’s posterior predictive distribution.
In what follows, Section 2 details the motivating application of inferring food (specifically apple) intake.
Section 3 outlines our proposed multiMarker framework and develops an efficient Metropolis-within-Gibbs
sampling strategy for Bayesian inference. Section 4 provides details of a thorough simulation study exploring
the performance of the proposed framework across a series of realistic settings. The multiMarker framework is
applied in the motivating context of inferring apple intake in Section 5, with the concluding Section 6 discussing
the application outcomes, the multiMarker framework and possible extensions. An R package, multiMarker,
is freely available through www.r-project.org to facilitate widespread use of the method, and with which all
results presented herein were produced.
2 Modelling the relationship between food intake and multiple
metabolomic biomarkers: apple intake as an example
In the present work we develop a model to estimate the relationship between apple intake and P = 4 uri-
nary biomarkers, identified using an untargeted metabolomics approach (McNamara et al. 2020). The four
urinary biomarkers are: Xylose, Epicatechin Sulfate, [(4-{3-[2-(2,4-dihydroxyphenyl)-2-oxoethyl]-4,6-dihydroxy-2-
methyoxyphenyl}-2-methylbut-2-en-1-yl)oxy] sulfonic acid, and Glucodistylin. Throughout the paper we will
refer to the third biomarker as (4− 3− [2− (2, 4− dihydroxyphenyl)− 2− oxoethyl]−DHMPMB − SA).
The data were collected as part of an intervention study, where a group of 32 participants consumed different
quantities of apple daily, over a three week intervention period. The intervention study was conducted as part of
the A-DIET research programme (www.ucdnutrimarkers.com/a-diet), which aims to identify new metabolomic
biomarkers of dietary intake. Data was available following consumption of D = 3 apple quantities: 50, 100 and
3
300 grams. Each intervention week was followed by a resting week. Biomarker data was available following
consumption of 50, 100 and 300 grams, respectively for 29, 28 and 29 participants, leading to a total of n = 86
observations. Throughout the paper we will treat the n = 86 observations as independent and this assumption is
assessed in Section 5. The original values for Epicatechin Sulfate, (4− 3− [2− (2, 4− dihydroxyphenyl)− 2−
oxoethyl] −DHMPMB − SA) and Glucodistylin caused computational instability (most values were larger
than 107) and consequently were scaled (see Appendix C). However, the transformation did not alter the
correlations between the four biomarkers. A visualization of the data is given in Figure 1. Three of the four
urinary biomarkers have similar median values for the first two apple quantities, and all biomarkers are highly
variable for the 300 grams apple quantity. Also, the boxplots corresponding to different apple quantities partially
overlap, indicating that such quantities can not be completely separated by biomarker values.
The intervention data are used to model the relationship between the panel of biomarkers and apple intake
(in grams). We also examine the ability of the model to predict apple consumption at a participant level, using
only the metabolomic biomarker measurements.
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Figure 1: Biomarker levels following consumption of different quantities of apple. Boxplots for the n = 86 observations on
the four biomarkers, for the three apple quantities (50, 100 and 300 grams).
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3 The multiMarker model
To quantify food (in this case apple) intake from a panel of biomarkers we propose a factor analytic framework
termed multiMarker. The proposed framework learns the relationship between the multiple biomarkers and food
quantity data and facilitates prediction of intake when only biomarker data are observed.
3.1 Model specification
Consider a biomarker matrix Y of dimension (n× P ), storing P different biomarkers measurements on a set
of n independent observations. The D food quantities considered in the intervention study are denoted by
X = {X1, . . . , Xd, . . . , XD}. Elements in X are ordered such that Xd < Xd+1. We assume that the biomarker
measurements are related to an unobserved, continuous intake value, for which the food quantities are proxies,
leading to the following factor analytic model:
yip = αp + βpzi + ip, ∀ i = 1, . . . , n, p = 1, . . . , P, (1)
where the (one dimensional) latent variable zi denotes the latent intake of observation i.
The αp and βp parameters characterize, respectively, the intercept and the scaling effect for the pth biomarker.
We assume a truncated Gaussian prior distribution, αp ∼ N[0,∞]
(
µα, σ
2
α
)
, for the intercept parameters. The
non-negative assumption is required as biomarker levels can not be negative. The pth scaling parameter βp
captures the effect of an increment in consumption of a given food on the observed level of biomarker p and a
truncated Gaussian prior distribution is also assumed, βp ∼ N[0,∞]
(
µβ , σ
2
β
)
.
The error term p is the variability associated with the pth biomarker; a precise biomarker will have a value
close to zero. As is common in factor analytic models, we assume that ip ∼ N (0, σ2p), where σ2p serves as a
proxy for the precision of the pth biomarker. Hence, the likelihood function conditional on z = (z1, . . . , zn)T is:
`(Y | α, β, z,Σ) =
P∑
p=1
n∑
i=1
(
−12 log
(
2piσ2p
)− 12σ2p (yip − αp − βpzi)2
)
, (2)
where Σ = diag(σ21 , . . . , σ2P ). As stated, the quantities of interest z = (z1, . . . , zn)T cannot be directly measured,
only their discretizations (the food quantities from the intervention study) are available which are therefore
employed to inform the distribution of the latent intakes. Thus, differently from standard factor analytic models,
here the scale of the latent variable plays a central role, and its accurate recovery is a central requirement of the
analysis.
3.2 Modelling the latent intakes
To specify a prior distribution for the latent intakes, we exploit the information available in the food quantities
from the intervention study. It is reasonable to assume that the latent intake of the ith observation, zi, will
be distributed around its corresponding consumed food quantity. Thus we assume a mixture of D truncated
Gaussian distributions as the prior distribution for the latent intakes:
zi ∼
D∑
d=1
pidN[0,∞]
(
Xd, σ
2
dτd
)
(3)
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The use of truncated distributions follows naturally from the definition of intake, which is non-negative. The
dth component in the mixture model represents the distribution of the intakes of the observations who were
administered the dth food quantity, and is therefore centered at Xd. The variances σ21 , . . . , σ2D represent food
quantity-specific intake variability, with lower values suggesting higher consumption-compliance. As the focus
here is on recovering the latent variable in its innate scale, the τd parameters serve as food quantity-specific
scaling factors. These parameters account for large or small gaps between subsequent food quantities and,
also, indirectly, for the possible difference in scale between the latent intakes and the biomarkers. Given the
application context, here the mixture weights pi = (pi1, . . . , piD) are known as they represent the proportion of
observations that have consumed each food quantity.
3.3 An MCMC algorithm for parameter estimation
We adopt a Bayesian approach to estimate the hierarchical model’s parameters, implemented through a Metropolis
within Gibbs Markov chain Monte Carlo (MCMC) algorithm. At each iteration of the algorithm, latent intakes
and model parameters are sequentially updated from full conditional distributions. Hyperprior distributions are
assumed on the prior parameters with the corresponding hyperparameter values fixed based on the data at hand,
following an empirical Bayes approach. Hyperparameter specifications are reported in the Appendix A.1. Figure
2 provides a graphical representation of the multiMarker model, with the update steps of the MCMC algorithm
detailed below.
Y
α β z σ2p
µα σ2α µβ σ
2
β τd σ
2
d
pid νP1 νP2
Xdmα mβ τβ νβ1 νβ2 νz1, νz2
Figure 2: Hierarchical structure of the multiMarker model. Shaded circles represent the data. Parameters and latent
variables are indicated with transparent circles and hyperparameters are indicated with no circles.
3.3.1 Biomarker-specific regression parameters
For the pth biomarker the truncated Gaussian prior distributions of both αp and βp are combined with the
likelihood function leading to the full conditional distributional distributions of αp and βp:
αp ∼ N[0,∞]
(
µ∗αp , σ
2∗
αp
)
; βp ∼ N[0,∞]
(
µ∗βp , σ
2∗
βp
)
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where
σ2∗αp =
σ2pσ
2
α
nσ2α + σ2p
;µ∗αp = σ
2∗
αp
[∑n
i=1
(
yip − βpzi
)
σ2p
+µα
σ2α
]
; σ2∗βp =
σ2pσ
2
β
σ2β
∑n
i=1 z
2
i + σ2p
;µ∗βp = σ
2∗
βp
[∑n
i=1 zi
(
yip − αp
)
σ2p
+µβ
σ2β
]
3.3.2 Error term’s variance parameter
Assuming an inverse gamma prior distribution for the pth variance term σ2p, with shape parameter νP1 and scale
parameter νP2, leads to the following full conditional distribution:
σ2p ∼ InvΓ
(
ν∗P1 =
n
2 + νP1, ν
∗
P2 =
1
2
n∑
i=1
(yip − αp − βpzi)2 + νP2
)
3.3.3 Latent intakes
To derive the full conditional distribution for the latent intake, we exploit the complete data representation of
its prior distribution:
zi | · · · ∼
D∏
d=1
[
pidN[0,∞](Xd, σ2dτd)
]cid
, cid =
1 if observation i consumed food quantity Xd,0 otherwise, for d =1, . . . , D.
where the observation labels ci = {ci1, . . . , ciD} and the mixture weights pid are known, given the structure of the
intervention study. Thus for observation i who consumed quantity Xd and has biomarkers yi, we may sample
the corresponding latent intake value from:
zi | · · · ∼ N[0,∞]
(
µ∗id, σ
2∗
id
)
, with σ2∗id =
(
P∑
p=1
β2pτdσ
2
d + σ2p/P
τdσ2dσ
2
p
)−1
, µ∗id = σ2∗id
[
P∑
p=1
βp
(
yip − αp
)
σ2p
+ Xd
τdσ2d
]
Further, assuming an inverse gamma prior distribution on the components’ variance parameters, σ2d ∼
InvΓ
(
νz1, νz2
)
, the full conditional distribution is:
σ2d ∼ InvΓ
(
ν∗z1, ν
∗
z2
)
, with ν∗z1 =
nd
2 + νz1, ν
∗
z2 = νz2 +
τd
∑n
i=1 1(xi = Xd)(zi − xd)2
2τd
,
where nd =
∑n
i=1 cid. The τd parameters are fixed according to food quantity values (τd =
xd
d2 ) to account for
different gaps between these and allow for good coverage of the latent intakes’ range.
3.3.4 Nuisance parameters
To allow for the uncertainty in the parameters of the prior distributions of αp and βp, hyperprior distributions
are specified for µα, µβ and σ2β . Specifically, µα ∼ N[0,∞]
(
mα, τασ
2
α
)
, µβ ∼ N[0,∞]
(
mβ , τβσ
2
β
)
, and σ2β ∼
InvΓ
(
νβ1, νβ2
)
, leading to the following full conditionals:
µg ∼ N[0,∞]
(
µ∗g, σ
2∗
g
)
, with σ2∗g =
τgσ
2
g
τgP + 1
, µ∗g = σ2∗g
[τg∑Pp=1 gp +mg
τgσ2g
]
,
σ2β ∼ InvΓ
(
ν∗β1, ν
∗
β2
)
, with ν∗β1 =
P + 1 + 2νβ1
2 , ν
∗
β2 = νβ2 +
τβ
∑P
p=1(βp − µβ)2 + (µβ −mβ)2
2τβ
,
where g = α, β. The set of hyperparameters
(
mα,mβ , τα, τβ , νβ1, νβ2
)
needs to be fixed in advance; some
practical guidelines are outlined in Appendix A.1. Finally, we fix the value of σ2α = 1, for identifiability.
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3.4 Predicting latent intakes
While the multiMarker framework infers the relationship between biomarker and food quantity data from an
intervention study, the aim is then to predict food intake when only biomarker data are available.
Let us assume there are n∗ observations for which biomarker data have been measured but no information on
their consumed food quantity is available. To predict the latent intake z∗j for observation j, j = 1, . . . , n∗, with
biomarker data y∗j = (y∗j1, . . . . , y∗jP )T , we reconsider the log-likelihood (2) as a function of the latent intakes
given the biomarker data:
p(z∗j | α, β,Σ, y∗j ) =
P∑
p=1
(
−12 log
(
2piσ2p
)− β2p2σ2p
(
z∗j −
(y∗jp − αp
βp
))2)
(4)
That is, p(z∗j | . . . ) is the truncated Gaussian distribution z∗j ∼ N[0,∞]
(
µz, σ
2
z
)
, where σ2z =
(∑P
p=1
β2p
σ2p
)−1 and
µz = σ2z
(∑P
p=1
βp(y∗jp−αp)
σ2p
)
. Thus we now treat the latent intakes as the response data, regressed on the biomarker
data. Then, combining (4) and (3) we derive the sampling distribution for z∗j :
p(z∗j | Ω) = N[0,∞]
(
µz, σ
2
z
) D∑
d=1
pidN[0,∞]
(
Xd, σ
2
dτd
)
=
D∑
d=1
pidN[0,∞]
(
µzσ
2
dτd +Xdσ2z
σ2dτd + σ2z
,
( 1
σ2dτd
+ 1
σ2z
)−1) (5)
where Ω = {pi1, . . . , piD, µz1, . . . , µzD, σ2zq, . . . , σ2zD}, µzd = µzσ
2
dτd+Xdσ
2
z
σ2
d
τd+σ2z
and σ2zd =
( 1
σ2
d
τd
+ 1σ2z
)−1, for d =
1, . . . , D. Combining (5) with the posterior distribution of the multiMarker model (see Appendix A.3) provides
the posterior predictive distribution for z∗j :
p(z∗j | z) ∝
∫
p(z∗j | Ω, z)p(Ω | z) dΩ =
∫
p(z∗j | Ω)p(Ω | z) dΩ (6)
where p(Ω | z) is the posterior distribution. Here p(z∗j | Ω) is a mixture distribution with weights pi = {pid}Dd=1.
As in the prediction setting only biomarker data are available, no food quantity information can be used to
assign participants to different mixture components and so the weights are unknown. Replacing the weights
with the fixed values from the intervention study would bias the predictions, as the food quantity consumption
pattern of the n∗ participants may be very different from that of the n participants used to train the multiMarker
model. Thus in the multiMarker model we model the weights as a function of the observed biomarker values, to
facilitate flexible and adaptive predictions.
3.4.1 Modelling components’ weights
Given the inherent ordering of the food quantities X1, . . . , XD in the intervention study, we employ an ordinal
regression model with Cauchit link function to model the weights pi. The Cauchit link function is more robust
than the standard logit or probit link functions and thus is suited to the often highly variable biomarker data.
The parameters of the ordinal regression model are inferred from the intervention study data using a slightly
modified specification of the multiMarker model, and then used later in the prediction step. Specifically, in the
multiMarker model with ordinal regression coefficients denoted θ and γ, we now assume:
p(pi | θ, γ,Y, c) =
n∏
i=1
D∏
d=1
pid(θd, γ, yi)cid =
n∏
i=1
D∏
d=1
[
Pr(xi ≤ Xd | θd, γ, yi)− Pr(xi ≤ Xd−1 | θd−1, γ, yi)
]cid
(7)
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where Pr(xi ≤ Xd | θd, γ, yi) = 1pi
[
arctan
(
1
2 (θd + γyi)
)
+ pi2
]
is the probability that participant i consumed less
than or equal to the food quantity Xd, given its P biomarker measurements yi, expressed through a Cauchit link.
The vector θ = {−∞ = θ0, θ1, . . . , θd, . . . , θD =∞} contains food quantity-specific intercepts. The γ parameter
is a P dimensional scaling coefficient for the biomarkers, expressing the contribution of each to the determination
of the mixture weights. These ordinal regression parameters are updated via a Metropolis Hastings step using
random walk proposal distributions within the MCMC algorithm. Details on their initialization are deferred to
Appendix A.2. Estimation of these weights-specific parameters requires intervention study data, and hence it is
performed simultaneously with, yet independently of, that of multiMarker model parameters (see Section 3.3).
We refer to this joint procedure as the learning phase of the multiMarker framework.
The model in (7) is similar to a mixture of experts model, a type of mixture model in which parameters are
modelled as a function of observed covariates. However, here the mixture weights are modelled as a function of
the observed response variable, as in the prediction step this variable changes its role to serve as a predictor.
Given the parametrization for the mixture weights pi in (7), we update the sampling distribution for z∗j (5) to:
p(z∗j | Ω, y∗j ) =
D∑
d=1
pid(θd, γ, y∗j )N[0,∞](µzd, σ2zd) (8)
where the definition of Ω is updated to Ω = {θ, γ, cj , µz1, . . . , µzD, σ2zq, . . . , σ2zD}, and y∗j are the biomarkers’
data for observation j. Finally, considering the updated definition of Ω and that of p(z∗j | Ω, y∗j ), we can rewrite
the posterior predictive distribution (6) as:
p(z∗j | z, y∗j ) ∝
∫
p(z∗j | Ω, y∗j )p(Ω | z) dΩ (9)
We sample from the posterior predictive distribution (9) in three steps. First, relevant model parameters, Ω, are
sampled from their full conditional and proposal distributions, the parameters of which are estimated in the
learning phase. Second, the labels cjd, d = 1, . . . , D, are computed, using current sampled weights parameter
values and novel biomarker data y∗j , for j = 1, . . . , n∗. Specifically, at the tth iteration we have that c
(t)
jd = 1,
if arg maxs pis(θ(t)s , γ(t), y∗j ) = pid(θ
(t)
d , γ
(t), y∗j ), and c
(t)
jd = 0 otherwise. Last, predicted latent intake values are
sampled from (8), conditioning on the current labelsand sampled model parameters Ω. We refer to the above
three step procedure as the prediction phase of the multiMarker framework. This three-step sampler results in
more refined latent intake predictions. Indeed, not inferring the n∗ labels and obtaining predictions by averaging
across the whole mixture distribution (8) leads to predicted intake values closer to the food quantities’ sample
mean X¯d = 1D
∑
dXd. This results in poor predictions for observations that are more likely to belong to a
component located near small or large food quantity values. A schematic representation of the model for the
components’ weights and of that for latent intake predictions is given in Figure 3.
4 Simulation study
Several simulation scenarios have been constructed to analyze the properties of the proposed approach. Perfor-
mance is assessed both from estimation and prediction perspectives. The terms “train” and “test” are used to
refer, respectively, to different simulated data employed in the learning and the prediction phases. To represent
a variety of real-world scenarios, different sample sizes, numbers of biomarkers and food quantity values have
9
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(b)
Figure 3: Hierarchical structure of (a) the components’ weights model and (b) that for latent intake predictions. Shaded
circles represent the data. Parameters and latent variables are indicated with transparent circles. No circles indicate
hyperparameters, except for z and Xd, which are conditioned on from the learning phase.
been considered. To depict common experimental settings, the number of biomarkers considered is P = (3, 6),
and the number of food quantities is D = (3, 6). The sample sizes of the training datasets considered are
n = (30, 60, 99, 150), ranging from a low sample size scenario to a larger sample size. The test sets have b0.4×nc
observations.
Three different specifications are considered for the αp and βp parameters, to represent different types
of biomarker measures. Also, across the P biomarkers, three different specifications are considered for σ2p,
to explore the impact of increasing biomarker variability: small (scenario 1 ), mixed (scenario 2 ) or large
(scenario 3 ) range of variance values. Finally, the mixture components’ parameters (Xd, σ2d, pid) employed reflect
real-world intervention study scenarios: “food quantities with stable increments” (“stable incremenents”), “food
quantities with increasing increments” (“increasing increments”), and “food quantities with decreasing increments”
(“decreasing increments”). Two settings are implemented for the components’ variances σ2d, corresponding to
low and high variability. We set pid ≈ 1D when simulating training datasets. Combinations of these settings (20
simulated datasets for each) are used to investigate different aspects of performance in three simulation studies
detailed below. Figure 4 illustrates two simulated training datasets with low and high biomarkers’ variability
levels.
For the MCMC algorithm (Sections 3.3 and 3.4.1), 30000 iterations were run, both in the learning and
the prediction phases, with the first 6000 being discarded. The τd parameters are fixed such that τd = Xdd2 to
account for different gaps between the intervention studies’ food quantities, and to allow for good coverage of
the latent intakes range. As discussed in Section 3.3 hyperparameters are fixed according to the observed data
with automatic procedures, allowing non-statisticians to easily use the proposed approach. Further details on
the simulation settings, hyperparameter specifications and initializations are deferred to Appendix A.1 and
Appendix B.
In the absence of comparable approaches for intake quantification in the presence of multiple biomarker data,
we compare our results with those obtained using Bayesian linear regression (BLR) and partial least squares
(PLS) regression. In BLR, the food quantities are regressed on a linear combination of the biomarkers in the
training data with the resulting parameters used to predict intake in the test data. In PLS, the food quantities
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Figure 4: Simulation study I. Examples of simulated biomarker data (P = 3, D = 3) under (a) the small (scenario 1) and
(b) large (scenario 3) biomarkers’ variability scenarios. Here, n = 60 with (a) “stable increments” and (b) “increasing
increments” .
are regressed on a dimensionally reduced representation of the biomarker data in the training set.
4.1 Simulation Study I: exploring biomarkers’ variability
Simulation study I assesses performance under increasing noise levels in the P biomarkers. In the case where
P = D = 3, we compare results from the three biomarker variability scenarios. Table 1 (Simulation Study I
columns) reports the median absolute errors in grams between true and estimated and predicted latent intakes.
Overall, for estimated intakes, absolute error values are quite low, with median values ranging from 7g
in scenario 1 (small biomarker variability) to 14g in scenario 3 (large biomarker variability). Notably, the
within-scenario error variability is low, and in all cases is commensurate with the median error. Moreover, the
absolute errors are relatively stable across increasing noise levels σ2p, suggesting robustness of the approach to
biomarker variability. Table 1 also shows that the estimated absolute errors under BLR and PLS are higher and
more uncertain than those obtained using the multiMarker approach. Also, the BLR and PLS errors increase
with increasing biomarker variability σ2p.
In terms of prediction the multiMarker approach performs well, but with larger errors in Scenario 3; however,
the data simulated under Scenario 3 are extreme and unlikely to be seen in real applications (see Figure 4).
The BLR prediction errors are much larger and more variable. Under PLS, the errors are comparable with
the proposed approach however, as is borne out in the application (see Section 5), error values under PLS
tend to be relatively low as predicted values tend to be close to the food quantities’ sample mean. While such
mean-prediction tendency yields good results in terms of median absolute error values, it corresponds to a lack
11
of precision in the predictions, with more extreme intakes being predicted in the middle of the intake range.
4.2 Simulation Study II: impact of the number of food quantities
While a small number of food quantities (e.g. D = 3) is practical and cost efficient a larger D could increase the
coverage of the intake range. Thus Simulation Study II investigates the impact of larger D on intake estimation
and prediction. We analyse simulated data with P = 3 biomarkers and D = 6 food quantities, and compare
results with Simulation Study I where D = 3.
Table 1 (Simulation Study II columns) reports the absolute errors computed between estimated and predicted
latent intakes and the truth where D = 6. As observed in Simulation Study I, the errors under BLR are large and
uncertain when compared to the multiMarker and PLS approaches which perform similarly when the number of
food quantities is large.
The multiMarker approach performs similarly in Simulation Studies I and II whereD = 3 orD = 6 respectively.
This suggests that the predictive benefit of employing of a larger number of food quantities is minimal. Also,
recalling that the the errors in Table 1 are summaries of a large variety of simulation settings, with different
food quantities and sample sizes, suggests that modelling the latent intake range with a mixture distribution is a
flexible and adaptive approach. Finally, in Simulation Studies I and II all of the other multiMarker parameters
(see Section 3) have been recovered within a 99% credible interval.
4.3 Simulation study III: intake quantification under model misspecification
The multiMarker model (3) assumes that the relationship between the latent intakes and the observed biomarkers
is linear. To assess the performance of the proposed approach in the presence of model misspecification, we have
simulated data according to the settings used in Simulation Studies I and II, but this time using a non-linear
generating relationship between the intakes and the biomarkers:
yip = αp + βpz2i + ip, ∀ i = 1, . . . , n, p = 1, . . . , P (10)
Here the scaling coefficients βp have been re-scaled to 10% of the values used in Simulation Studies I and II (see
Appendix B), to obtain simulated biomarker data ranges similar to those in the two previous Simulation Studies.
Table 1 (Simulation Study III columns) again reports the absolute errors between estimated and predicted
latent intakes and the true values. Here, error values are low and similar to those computed under Simulation
Studies I and II. Indeed, median error values are always lower than 50g in the prediction setting, indicating
that true intakes can still be recovered quite well, even when the underlying model is misspecified. This is
due to the role of the mixture distribution on the latent intake, which anchors the intakes around the food
quantities. However, the model parameters are hardly ever recovered and often overestimated, indicating that
the model misspecification is absorbed by their estimates. The price of biased parameters estimates is a relatively
low one to pay in this context, as our goal is to obtain reliable predictions of intake. Further, the range of
errors confidence intervals is narrower in Simulation Study III than in the previous two studies. However,
the results of the present study and those from Simulation Study I and II can only be partially compared.
Indeed, recall that hyperparameters values are fixed across all Simulation Studies to allow comparability between
parameter estimates. For a given set of hyperparameters values, the quadratic relationship between intakes
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and biomarkers in Simulation Study III produces biomarker data which tend to exhibit greater separation in
biomarker distributions between food quantities that are far apart from each other, when compared to biomarker
data from Simulation Studies I and II (see Appendix B).
Finally, comparison with the BLR and PLS results yields similar conclusions to those presented in Simulation
Studies I and II. Further discussion of the Simulation Studies is deferred to Appendix B.
Table 1: Simulation studies’ results. Median (95% CI width) absolute error values (in grams) computed between true and
estimated (E) or predicted (P) latent intakes. The values are reported for the three simulation studies (I,II,III) and the
three biomarkers’ variability scenarios (S.1,S.2,S.3). Results for the multiMarker (MM) model are reported, as well as
those from Bayesian linear regression (BLR) and PLS (PLS) regression.
Simulation Study
I II III
Model S.1 S.2 S.3 S.1 S.2 S.3 S.1 S.2 S.3
MM
E 7(7) 8(6) 14(11) 8(7) 7(6) 10(6) 8(10) 9 (8) 16(5)
P 7(16) 9(21) 31(57) 8(27) 10(38) 41(48) 8(15) 9(13) 36(9)
BLR
E 8(25) 10(33) 40(47) 9(25) 11(33) 40(41) 14(3) 14(7) 39(5)
P 29(151) 69(255) 135(103) 43(153) 82(257) 125(142) 98(28) 69(82) 108(20)
PLS
E 8(25) 14(34) 40(47) 9(25) 15(35) 41(41) 14(3) 14(7) 47(5)
P 9(26) 15(37) 42(50) 9(29) 15(38) 44(42) 14(3) 15(9) 50(5)
5 Application of the multiMarker framework to biomarkers associ-
ated with apple intake
As detailed in Section 2, the motivating application was to infer the relationship between four biomarkers and
apple intake from an intervention study, with a view to predicting intake when only the four biomarkers are
available. The multiMarker framework was employed to infer the relationship between the biomarkers and food
intake, using 30000 MCMC iterations and discarding the first 6000, on a Intel(R) Core(TM) i7-8565U@1.80GHz
computer. Model hyperparameters were fixed as discussed in Appendix A.1.
Here we use leave-one-out cross validation to assess predictive performance on the apple data. Thus, n = 86
models were fitted, each with a different set of (n − 1) observations. In each case, the intake for the left out
observation was then predicted using its biomarker data only. The MCMC algorithms were run several times
and demonstrated no substantial difference in the parameters and latent intake predictions. The computation
time was approximately 3.47 minutes per model in the learning phase, and 6.78 seconds per data set in the
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prediction phase. Details of Expected Sample Size (ESS) values are available in Appendix C.
Results from the leave-one-out cross validation procedure are shown in Figure 5. Figure 5(a) shows boxplots of
the median predicted intakes, computed from the latent intake posterior predictive distributions, split according
to the true allocated apple quantity. Intake predictions are concentrated around the true apple intake quantities,
with increasing variability in the predictions observed for those allocated the third quantity of 300 grams. This
is not unexpected, as biomarker values related to the third apple quantity are quite variable (see Figure 1). Only
a few observations have predictions far from their true apple quantities. Indeed, the median absolute difference
between predicted intakes and actual intake is 62 grams for the 50 grams apple quantity group, 33 grams for the
100 grams quantity and 123 grams for the 300 grams quantity. Differences between apple quantities and median
predicted intake values are further visualized in Figure 5(b). The 95% credible intervals for these differences are
illustrated, showing that in general the latent intake posterior predictive distributions include the true apple
quantity values. Overall, there is good agreement between apple quantities and predicted intake, especially
within observations allocated the 50 and 100 grams quantities.
To further visualize the results, Figure 6 presents posterior predictive intake distributions, for 6 observations,
two for each apple quantity. Plots on the left side of Figure 6 correspond to accurately predicted intakes, while
those on the right are poorly predicted. When intakes are correctly inferred, the range of the posterior predictive
distribution does not incorporate apple quantities far from the truth (e.g. observations 13, 32 and 82). For poorly
predicted intakes from the 50 or 100 gram apple quantities, the estimated posterior predictive distributions
have much higher uncertainty (e.g. observations 1 and 39). For observations allocated to the 300 grams apple
quantity, those with poor predictions tend to have notably underestimated predicted intakes (e.g. observation
73), with a relatively narrow associated posterior predictive distribution range. Similar posterior predictive
distributions to those presented in Figure 6 have been obtained for the remaining observations. Notably the
observations with accurate predictions had largest posterior mean apple quantity probability of the correct apple
quantity while for those poorly predicted this was not the case.
For comparative purposes, BLR and PLS regression were also used to predict apple intake via leave-one-out
cross validation. Similar to the observed performance in the simulation studies, both methods proved unable
to give precise intake predictions, with most predictions around the average of the three apple quantities
(≈ 150 grams). Furthermore, 95% credible intervals obtained using BLR are more than twice the size of
those obtained under the multiMarker framework, indicating low reliability of the predictions. Further, the
uncertainty quantification under PLS regression was not useful, as the constructed 95% confidence intervals via
cross validation yielded very narrow ranges. Further details on these results are deferred to Appendix C.
To assess whether treating the n = 86 observations as independent was appropriate, we repeated the learning
phase using slightly modified versions of the dataset. Specifically, we constructed modified versions of the
original dataset such that the same participant appeared only once i.e. each subject is present in only in one
apple quantity, which was selected at random. This procedure was repeated 100 times, and each time the
multiMarker model was fitted to the modified dataset. Table 2 presents the posterior median parameter estimates
obtained from fitting the model to the original data and to the modified datasets. For the αp, βp, σp parameters,
dimensions 1 to 4 correspond to the four biomarkers, while for the σd parameter the dimensions correspond
to the three apple quantities. It is clear that the median estimates are similar. Also, posterior medians of the
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parameters from the original data are always contained in the corresponding 95% credible intervals inferred from
the modified datasets. These results suggest the inference is robust to our assumption of independence between
the n = 86 observations.
Table 2: Posterior median (95% CI width) parameter values inferred from the original apple data, and average posterior
median (average 95% CI width) parameter values inferred from the modified apple datasets.
Parameter
Data Dimension αp βp σp σd
Original
1 0.351 (0.725) 0.002 (0.004) 1.486 (0.411) 4.145 (2.763)
2 0.673 (0.855) 0.003 (0.005) 1.501 (0.430) 6.734 (6.774)
3 0.875 (1.009) 0.005 (0.005) 1.652 (0.497) 10.429 (13.220)
4 1.005 (0.943) 0.004 (0.005) 1.588 (0.505) -
Modified
1 0.409 (0.953) 0.002 (0.005) 1.503 (0.784) 3.834 (3.446)
2 0.659 (1.231) 0.003 (0.005) 1.509 (0.781) 5.857 (7.026)
3 0.851 (1.526) 0.005 (0.006) 1.689 (0.882) 9.634 (18.109)
4 0.933 (1.527) 0.004 (0.008) 1.624 (0.856) -
6 Discussion
Motivated by the need to infer the relationship between metabolomic biomarkers and food intake to faciltate future
intake predictions, we have introduced the general and flexible multiMarker framework. The proposed framework
builds upon two classical regression models, multiple linear regression and ordinal regression, combining them in
the wider frameworks of factor analysis and mixture of experts models. The developed multiMarker framework
facilitates inference of the relationship between multiple biomarkers and food quantities, and allows for prediction
of intake from multiple biomarkers data. The multiMarker framework advances on current approaches which
focus on categorical intake quantification by providing more detailed predictions. Moreover, as the method is
embedded in a Bayesian framework, uncertainty quantification is available, which is an important concern in
both the application domain and in a prediction context.
Although the proposed approach has been motivated by the specifications of the A-DIET study, the overall
multiMarker framework is general and designed to be accessible to non-statisticians. In the multiMarker
framework, the extra layer of complexity introduced by the latent variable and associated model parameters
bestows the advantage of more refined estimates and allows the model to adapt to different scenarios in the data.
Furthermore, modelling the weights of the mixture distribution using a mixture of experts framework guides
the quantitative prediction, informing the latter on which part of the intake range is to be considered when
predicting intake. Unlike previous approaches, we explicitly model the ordinal nature of the food quantities.
The multiMarker framework ability to model the relationship between biomarkers and food intake and
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Figure 5: Apple intake predictions (in grams), obtained using the multiMarker framework. (a) Boxplots for the median
predicted intakes, grouped by observed apple quantities. For clarity, horizontal red lines indicate the apple quantity values.
(b) Dots represent the difference between posterior median predicted intake and known apple quantity, with vertical lines
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Figure 6: Posterior predictive distributions of apple intake (in grams) for 6 observations. Orange and purple lines denote
median predicted intake and known apple quantity, respectively. Posterior median apple quantity probabilities are also
reported in the top horizontal bar in each plot. 17
to predict food intake from biomarker data was demonstrated on apple data collected under the motivating
A-DIET research programme. Leave-one-cross validation results showed that generally intake predictions were
concentrated around the true apple quantities. Comparison with existing regression models showed that the
multiMarker framework was able not only to provide useful uncertainty quantification, but also much more
reliable apple intake predictions.
The proposed approach was also assessed in an extensive simulation study, where a large variety of biomarker
data have been generated to check model performances under, among other things, different levels of biomarker
or intake variability. Furthermore, performances under model misspecification have been verified. In all of the
cases the framework performed well, as intake values and their range were recovered with low error, even in a
model misspecification context.
The proposed framework allows quantification of any unobserved quantity of interest for which prior
information on its scale is observed (here, food quantities) and for which proxies can be measured (here,
biomarkers). Furthermore, the observed variables’ scales are not relevant to recover that of the latent variable.
Indeed, a collection of hyperparameters has been introduced to directly regulate different ranges between the
biomarkers. Such a feature is appealing for researchers, as biomarkers for the same intake could correspond to
quite different measurement ranges, due to their sources (blood, urine, etc), the instrument used for collection
and so on.
Although designed for a particular problem, the quantification of apple intake from a panel of urinary
biomarkers, the proposed method has general applicability outside of nutrition. Indeed, the framework could
have applicability in any scenario where multiple outcomes are associated with an unobserved variable of interest,
such as in toxicology or social science studies. Possible extensions to the proposed model are many and varied,
including explicitly modelling the repeated biomarker measurements in the same group of participants. Further,
the introduction of subject-specific covariates in the latent intake mixture weights, to allow a more flexible fit of
the model, would be feasible. Thus there is much potential in the use of latent variable models to infer food
intake.
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A Posterior distribution and MCMC algorithm
Considering the multiMarker model’s likelihood, prior and hyperprior distributions, the posterior distribution is:
P (Ω | Y) = L(Y | α, β, z,Σ)p(α | µα, σ2α)p(µα | mα, τα, σ2α)p(β | µβ , σ2β)p(µβ | mβ , τβ , σ2β)p(σ2β | νβ1, νβ2)
p(z | pi,X1, . . . , XD, pi, σ21 , . . . , σ2D)p(pi | θ, γ,Y, c)p(γ)p(θ)p(σ21 , . . . , σ2D | νz1, νz2)p(Σ | νp1, νp2)
(11)
where for brevity Ω denotes the set of model parameters.
A.1 Hyperparameter settings
Given an observed dataset, hyperparameter values are fixed automatically according to the following procedures.
The overall means mα and mβ are fixed, respectively, as the estimated intercept and slope coefficient of the
multiple linear regression defined using biomarkers as response variable and food quantity values as predictor.
Variances’ hyperparameters are fixed differently according to the parameter to which they refer: (νβ1, νβ2) = (2, 3),
(νp1, νp2) = (1, n), and (νz1, νz2) = ({D, . . . , 1}, n). Regarding the α and β vector of parameters, their values are
initialized solving the following system of equations:∑
(xi=Xd)
(yip) ≈ αp + βpxd for p = 1, . . . , P and d = 1, . . . , D.
Biomarkers’ error variances are initialized exploiting the definition of estimated error variances under the
factor analytic model, adjusted for the extra variability brought in by the latent intakes prior distribution:
Σ = V̂ (Y)− 1DββT . Last, mixture components’ variance parameters are initialized with the following values:
σ2d =
1
P
P∑
p=1
V̂ (Ypd)− σ2α − σ2p
σ2β
where V̂ (Ypd) = ˆvar
(
1(xi = Xd)yip
)
.
A.2 Components’ weights
The prior distributions for the θ = {θ0, θ1, . . . , θD} weights’ parameters are defined to represent the constrained
characteristic of ordinal data, that is: X1 < · · · < Xd < · · · < XD. These constraints correspond to the
following in terms of model parameters: θ0 < · · · < θd < · · · < θD. A natural choice for the corresponding prior
distributions is the following:
θd ∼ N(θd−1,θd+1)
(
0, σ2θd
)
, for d = 1, . . . D − 1
Given the above prior distributions, θd parameters are updated with a random walk Metropolis Hastings step
inside the MCMC algorithm. Hyperparameters σ2θd , d = 1, . . . , (D − 1), are fixed to some value σ2θd <= 2. Small
variations around this threshold have been tested and did not produce any substantial difference in the θd
parameter estimates. Further, biomarkers’ intercepts γ = {γ1, . . . , γP } have been given standard Gaussian prior
distributions. Parameter estimates are initialized via their corresponding estimates obtained with the ordinalNet
package, available on CRAN (https://CRAN.R-project.org/package=ordinalNet).
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A.3 Latent intake posterior predictive distribution
In Section 3.4 we have introduced a sampling distribution for the latent intakes, to be used in a prediction
framework. This distribution was derived as the product of two terms, the first being the log-likelihood of the
model, expressed as a function of the latent intakes:
`(y∗j | α, β, z∗j ,Σ) = p(z∗j | α, β, y∗j ,Σ) =
P∑
p=1
p(z∗j | αp, βp, y∗j , σ2p)
=
P∑
p=1
(
−12 log
(
2piσ2p
)− 12σ2p
(
z∗j βp −
(
y∗jp − αp
))2)
=
P∑
p=1
(
−12 log
(
2piσ2p
)− β2p2σ2p
(
z∗j −
(y∗jp − αp
βp
))2)
∝
P∑
p=1
(
− β
2
p
2σ2p
(
z∗j −
(y∗jp − αp
βp
))2)
∝ −12z
∗2
j
( P∑
p=1
β2p
σ2p
)
+ z∗j
( P∑
p=1
βp(y∗jp − αp)
σ2p
)
= − 12σ2z
z∗2j +
µz
σ2z
z∗j ,
The second term is the mixture distribution presented in Section 3.2. The product of these two terms can be
expressed as a mixture distribution:
p(z∗j | Ω) = N[0,∞]
(
µz, σ
2
z
) D∑
d=1
pidN[0,∞]
(
Xd, σ
2
dτd
)
=
D∑
d=1
pidN[0,∞]
(
µz, σ
2
z
)N[0,∞](Xd, σ2dτd)
=
D∑
d=1
pidN[0,∞]
(
µzσ
2
dτd +Xdσ2z
σ2dτd + σ2z
,
( 1
σ2dτd
+ 1
σ2z
)−1) = D∑
d=1
pidN[0,∞](µzd, σ2zd)
(12)
where Ω = {µz1, . . . , µzD, σ2zq, . . . , σ2zD}. Combining p(z∗j | Ω) with the posterior distribution of the multiMarker
model provides the posterior predictive distribution for z∗j : p(z∗j | z) ∝
∫
p(z∗j | Ω)p(Ω | z) dΩ, where
p(Ω | z) = L(Y | α, β, z,Σ)p(α | µα, σ2α)p(β | µβ , σ2β)p(z | {Xd, σ2d, τd, pid}Dd=1)p(Σ | νp1, νp2)
When the parametrization for the components weights introduced in Section 3.4.1 is considered, the posterior
predictive distribution for z∗j is updated to: p(z∗j | z, y∗j ) ∝
∫
p(z∗j | Ω, y∗j )p(Ω | z) dΩ, where
p(Ω | z) =L(Y | α, β, z,Σ)p(α | µα, σ2α)p(β | µβ , σ2β)p(Σ | νp1, νp2)
p(z | {Xd, σ2d, τd, pid}Dd=1)p({pid}Dd=1 | θ, γ,Y, c)p(θ)p(γ)
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B Additional simulation study details
In the simulation studies described in the paper, biomarkers’ intercepts and scale coefficients (α, β) are sampled
from their prior distributions with hyperparameters:
{µα, µβ , σα2 , σ2β} = {(1, 0.01, 1, 0.01), (20, 0.1, 4, 0.1), (100, 1, 14, 1)}
These hyperparameter specifications correspond to small, mixed and large range biomarker values, and are
used to represent different types of biomarker measures (as for example measurements coming from different
instruments or measurements non normalised by osmolality). Regarding the error variance terms σ2p, these
values are sampled from Inverse Gamma distributions with expected values dependent on the biomarkers’ range
considered: (1, 3, 15) for small variances and (3, 20, 100) for large ones, respectively in the small, mixed and
large biomarkers’ range frameworks. Values for Xd are sampled from D zero-truncated Gaussian distributions
with means µXd ranging in between 30 and 250, with µXd < µXd+1 . Three different settings are explored to
represent “food quantities with stable increments”, “food quantities with increasing increments”, and “food
quantities with decreasing increments”. In the first setting (“stable increments”), means µXd are equispaced,
that is d(µXd−1 , µXd) = d(µXd , µXd+1). Instead, in the second and third settings we have that d(µXd−1 , µXd) <
d(µXd , µXd+1) and d(µXd−1 , µXd) > d(µXd , µXd+1), respectively. Values for σ2d are sampled from Inverse Gamma
distributions with either expected value of 10 (small variances) or of 14 (large variances).
B.1 Simulation study III
Figure 7 reports an example of a comparison between biomarker data simulated in Simulation Study I (linear
relationship) and Simulation Study III (non-linear relationship), obtained using similar specifications of the
model parameters. In the example, n = 60 is considered, under the “increasing increments” food quantities
setting.
B.2 Comparison with PLS and Bayesian linear regression models
To compare the three Simulation Studies, Figure 8 presents the median prediction absolute error ratios1 obtained
using either PLS or Bayesian linear regression models, and the multiMarker model. In approximately 50% of
the cases, prediction error values from a Bayesian linear regression model are up to ten times those from the
multiMarker model. For the other half of the cases, Bayesian linear regression performs up to 50 times worse
than the proposed one in terms of prediction error, with greater differences observed in Simulation Study I. PLS
regression performs worse than the multiMarker model in approximately 85% of the simulations, with prediction
error values up to two to four times those of the proposed model. In the 15% of cases in which the error ratio
values favor the PLS model, error values from the multiMarker framework are always less than twice those
obtained with PLS regression.
1Absolute errors are computed between the estimated or predicted intakes and the true ones.
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Figure 7: Simulation study I and III. Examples of simulated biomarker data (P = 3, D = 3) under the small (scenario 1)
biomarkers’ variability scenario, and Simulation Study I (black boxplots) and Simulation Study III (grey boxplots). Here,
n = 60 with “increasing increments” in food quantities.
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(a) Bayesian linear regression vs. the multiMarker model.
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(b) PLS regression vs. the multiMarker model.
Figure 8: Absolute error ratios between (a) the Bayesian linear regression and (b) PLS regression models and the
multiMarker model. Absolute error values are computed between true and predicted latent intakes. Results are presented
for the three different Simulation Studies. The red line in the plots corresponds to an equivalence of the models considered,
with values above this line indicating a better performance by the multiMarker model.
24
C Apple intake data
C.1 Data scaling
The original values for Epicatechin Sulfate, (4−3− [2−(2, 4−dihydroxyphenyl)−2−oxoethyl]−DHMPMB−
SA) and Glucodistylin biomarkers caused computational instability (most values were larger than 107) and
consequently were scaled. Given a biomarker p, the corresponding scaled values y˜ip are computed as follows:
y˜ip =
yip − y¯p
sd(yp)
+ 2
∣∣∣∣ mini=1,...,n(yip − y¯psd(yp)
)∣∣∣∣
where yip are the original measurements, i = 1, . . . , n. The original measurements mean and standard deviation
are denoted with y¯p and sd(yp), respectively. The transformation did not alter the correlations between the four
biomarkers.
C.2 Comparison to BLR and PLS regression
Figure 9 reports plots that are analogous to those in Figure 5 of the paper, obtained using either BLR or PLS
regression, for a comparison.
C.3 MCMC diagnostics
Table 3 reports a summary of the ESS (Expected Sample Size) values for the model parameters (30000 MCMC
iterations considered). Figures 10 and 11 report, respectively, the estimated posterior distributions for the αp
and βp parameters, p = 1, . . . , P , in the apple intake data. In addition, Figures 12 and 13 report, respectively,
the trace plots for the estimated αp and βp parameters, p = 1, . . . , P , in the apple intake data.
Table 3: Apple data. Summary of the ESS (Expected Sample Size) values for the model parameters (30000 MCMC
iterations considered).
Parameter
µα µβ σ
2
β α β σ
2
p σ
2
d z γ θ
min 1813 14786 14586 5233 5381 18105 1008 19380 12469 11202
median 1813 14786 14586 6524 6659 19069 1094 26310 12554 11575
Max 1813 14786 14586 18238 18917 20001 1293 28141 12639 12812
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Figure 9: Plots (a) and (b): intake predictions (in grams), obtained fitting the PLS regression model and using leave one
out cross validation. Plots (c) and (d): intake predictions (in grams), obtained fitting the Bayesian linear regression model
and using leave one out cross validation. These plots are analogous to those in Figure 5 of the paper.
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(d) Glucodistylin.
Figure 10: Apple data. Estimated posterior distributions for the αp parameters, p = 1, . . . , P .
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(d) Glucodistylin.
Figure 11: Apple data. Estimated posterior distributions for the βp parameters, p = 1, . . . , P .
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(b) Epicatechin Sulfate.
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(c) (4−3−[2−(2, 4−dihydroxyphenyl)−2−oxoethyl]−
DHMPMB − SA).
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(d) Glucodistylin.
Figure 12: Apple data. Trace plots for the estimated αp parameters, p = 1, . . . , P . Correlation values computed between
the four intercept parameters’ chains lie in (−0.004, 0.013).
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Figure 13: Apple data. Trace plots for the estimated βp parameters, p = 1, . . . , P . Correlation values computed between
the four scaling coefficients parameters’ chains lie in (−0.004, 0.008).
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